Transcriptomics

Dataset Information

0

Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling


ABSTRACT: Imbalances in glucose and energy homeostasis are at the core of the worldwide epidemic of obesity and diabetes. Here, we illustrate an important role of the TGF-beta/Smad3 signaling pathway in regulating glucose and energy homeostasis. Smad3 deficient mice are protected from diet-induced obesity and diabetes. Interestingly, the metabolic protection is accompanied by Smad3-/- white adipose tissue acquiring the bioenergetic and gene expression profile of brown fat/skeletal muscle. Smad3-/- adipocytes demonstrate a marked increase in mitochondrial biogenesis, with a corresponding increase in basal respiration, and Smad3 acts as a repressor of PGC-alpha1 expression. We observe significant correlation between TGF-beta1 levels and adiposity in rodents and humans. Further, systemic blockade of TGF-beta1 signaling protects mice from obesity, diabetes and hepatic steatosis. Together, these results demonstrate that TGF-beta signaling regulates glucose tolerance and energy homeostasis and suggest that modulation of TGF-beta1 activity might be an effective treatment strategy for obesity and diabetes.

ORGANISM(S): Mus musculus

PROVIDER: GSE28598 | GEO | 2011/07/13

SECONDARY ACCESSION(S): PRJNA139107

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-07-12 | E-GEOD-28598 | biostudies-arrayexpress
| PRJNA139107 | ENA
2018-07-01 | GSE100706 | GEO
2017-10-28 | E-MTAB-4085 | biostudies-arrayexpress
2024-05-31 | GSE267493 | GEO
2023-07-25 | GSE228492 | GEO
2023-07-25 | GSE228490 | GEO
2023-07-25 | GSE200193 | GEO
2023-07-25 | GSE200192 | GEO
2024-03-21 | GSE255540 | GEO